EUVIMED · CrossrefZeitschrift
Cardiovascular Drugs and Therapy
ISSN 0920-3206 · Springer Science and Business Media LLC
Neueste Artikel
Methodological Considerations in Evaluating Plaque Stabilization in Patients with High Lipoprotein(a)
Comparative Cardiovascular, Lipid, and Safety Effects of Lipid-Modifying Therapies in Diabetes: An Agent-, Class-, and Dose-Level Network Meta-Analysis
Anatomophysiopathology of Vein Graft Arterialization: The Potential Damage of Venous Valves
Complement Component C4B Prioritization Through Drug‒Target Mendelian Randomization and Proteomic Analysis Reveals a Novel Therapeutic Target for Calcific Aortic Valve Stenosis
GLP-1 Agonists and Risk of Atrial Fibrillation in Non-Dialysis Chronic Kidney Disease
Comparing the 2025 ESC/EAS Focused Update and the 2026 ACC/AHA Dyslipidemia Guideline: Convergences, Divergences, and Practical Implications
Re: Differential Outcomes of Beta-Blockers According to Heart Rate Following Myocardial Infarction with Reduced Left Ventricular Ejection Fraction
Shenfu Injection Inhibits Cardiac Fibroblast Activation and Improves Myocardial Fibrosis by Down-regulating M1 Macrophage-Derived Exosomal miR-155-5p
Cardiovascular Genetic Epidemiology in the Genome-Wide Era: From Association Discovery to Mechanistic Dissection and Clinical Translation
Impact of Nitric Oxide Metabolites On Early Perioperative Biochemical Changes and Postoperative Complications in High-BMI Patients Undergoing On-Pump CABG: an Exploratory Observational Cohort Study
Association of In-Hospital Dapagliflozin Initiation with Favorable left Ventricular Remodeling in Patients with Acute Myocardial Infarction and Heart Failure: A Retrospective Cohort Study
Sennoside A Ameliorates Myocardial Fibrosis After Myocardial Infarction by Binding to KDM4B and Regulates IRX2 Expression
Effects of Age, BMI and Creatinine Clearance on Edoxaban Plasma Concentrations in Non-Valvular Atrial Fibrillation Patients
DNA/RNA Methylation-Driven Coronary Microvascular Dysfunction: Emerging Pathogenic Mechanisms and Therapeutic Opportunities for Heart Failure in Diabetes
Improving the Cardiorenal Usability of Endothelin Receptor Antagonism in Albuminuric Chronic Kidney Disease: A Testable Role for SGLT2 Inhibitor–based Mitigation of Fluid Retention
Circulating Circ_0089762 Predicts Adverse Outcomes in Acute Myocardial Infarction Via Regulating miR‑938/STAT3‑Mediated Endothelial Dysfunction
Temporal Coordination of Angiogenic, Nitric Oxide, and Endothelin Pathways in Vascular Adaptation to Hypoxia and Reoxygenation
Fibroblast Growth Factor 7 Limits Fibroblast-Driven Matrix Remodeling in Abdominal Aortic Aneurysm
The Apelin-APJ Axis in Heart Failure: Mechanistic Insights, Clinical Evidence, and Translational Challenges
Comparative Analysis of Antithrombotic Strategies Following Valve-in-Valve Transcatheter Aortic Valve Implantation Using Real-World Registry Data
Pericardial Extracellular Vesicles As Drug Carriers: Beyond Native Vesicle Therapy in Heart Failure
Methodological Considerations Regarding “Impact of Nitric Oxide Metabolites on Early Perioperative Biochemical Changes and Postoperative Complications in High-BMI Patients Undergoing On-Pump CABG”
Guideline-directed Low-density Lipoprotein Cholesterol Management After Acute Coronary Syndrome in Patients With Mental Illness: a Population-based Study
Early Aspirin Discontinuation After Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials
“In-Hospital Initiation of SGLT-2 Inhibitors in Acute Heart Failure: A Systematic Review and Meta-Analysis of Clinical, Decongestion, and Safety Outcomes”
Endpoint Inconsistency and Overinterpretation of Early Biomarkers After CABG
Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury
Cellular Senescence in Diabetic Cardiomyopathy: Mechanistic Insights and Therapeutic Perspectives
Lentinan Attenuates Experimental Atherosclerosis by Regulating Macrophage HCK/GUSB Expression and Amino Acid Metabolic Remodeling
Cardiotoxicity of Targeted Cancer Therapies: Expanding the Translational Horizon
Jahrgänge
2026 · 2242025 · 2072024 · 1482023 · 1302022 · 1212021 · 1162020 · 932019 · 812018 · 732017 · 612016 · 702015 · 692014 · 732013 · 702012 · 652011 · 832010 · 562009 · 722008 · 642007 · 712006 · 562005 · 602004 · 712003 · 572002 · 772001 · 862000 · 741999 · 631998 · 961997 · 1141996 · 921995 · 1141994 · 1191993 · 1291992 · 1031991 · 1811990 · 2241989 · 1321988 · 1311987 · 50
EUVIMED